EUVIMEDEUVIMED entdecken
Crossref

Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation

Jinwoo Park, Minji Kim, Seung Lee

Pharmaceutical Sciences and Drug Design · 2026 · 6 (2) · 130-148

DOI: 10.51847/p78cofv6m5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2026. Verfasst von Jinwoo Park und 2 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim was to examine how the cationic nanocarrier leciplex (LPX) could boost the oral bioavailability of vancomycin hydrochloride (VAN) through enhancement of its permeation across the intestinal wall. A D-optimal design was employed to evaluate the impact of several variables—namely, lipid molar ratio, cationic surfactant molar ratio, cationic surfactant type, and lipid type—on the attributes of LPX, such as entrapment efficiency (EE%), particle size (P.S.), polydispersity index (P.I.), zeta

Zitieren

APA

Park, J., Kim, M., & Lee, S. (2026). Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation. Pharmaceutical Sciences and Drug Design, 6(2), 130-148. https://doi.org/10.51847/p78cofv6m5

Vancouver

Park J, Kim M, Lee S. Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation. Pharmaceutical Sciences and Drug Design. 2026;6(2):130-148. doi:10.51847/p78cofv6m5

BibTeX
@article{Park2026,
  author = {Park, Jinwoo and Kim, Minji and Lee, Seung},
  title = {Cationic Leciplex Nanocarriers for Oral Delivery of Vancomycin Hydrochloride: Design Optimization and Pharmacokinetic Evaluation},
  journal = {Pharmaceutical Sciences and Drug Design},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {130--148},
  doi = {10.51847/p78cofv6m5}
}
Kostenlos starten →